Report Detail

Other Global Pharmaceutical Aseptic Fill/Finish CMO Market Size, Status and Forecast 2020-2026

  • RnM4109807
  • |
  • 31 July, 2020
  • |
  • Global
  • |
  • 134 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pharmaceutical Aseptic Fill/Finish CMO Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Ampoule Filling Services
    • 1.2.3 Vial Filling Services
    • 1.2.4 Aseptic Prefilled Syringes/Sterile Syringe Filling Services
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Pharmaceutical Aseptic Fill/Finish CMO Market Share by Application: 2020 VS 2026
    • 1.3.2 Vaccines
    • 1.3.3 Commercial Drug products
    • 1.3.4 Clinical Drug products
    • 1.3.5 Antibiotics
    • 1.3.6 Diagnostics and Reagents
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharmaceutical Aseptic Fill/Finish CMO Market Perspective (2015-2026)
  • 2.2 Global Pharmaceutical Aseptic Fill/Finish CMO Growth Trends by Regions
    • 2.2.1 Pharmaceutical Aseptic Fill/Finish CMO Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Pharmaceutical Aseptic Fill/Finish CMO Historic Market Share by Regions (2015-2020)
    • 2.2.3 Pharmaceutical Aseptic Fill/Finish CMO Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pharmaceutical Aseptic Fill/Finish CMO Players by Market Size
    • 3.1.1 Global Top Pharmaceutical Aseptic Fill/Finish CMO Players by Revenue (2015-2020)
    • 3.1.2 Global Pharmaceutical Aseptic Fill/Finish CMO Revenue Market Share by Players (2015-2020)
  • 3.2 Global Pharmaceutical Aseptic Fill/Finish CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Pharmaceutical Aseptic Fill/Finish CMO Revenue
  • 3.4 Global Pharmaceutical Aseptic Fill/Finish CMO Market Concentration Ratio
    • 3.4.1 Global Pharmaceutical Aseptic Fill/Finish CMO Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Aseptic Fill/Finish CMO Revenue in 2019
  • 3.5 Key Players Pharmaceutical Aseptic Fill/Finish CMO Area Served
  • 3.6 Key Players Pharmaceutical Aseptic Fill/Finish CMO Product Solution and Service
  • 3.7 Date of Enter into Pharmaceutical Aseptic Fill/Finish CMO Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Aseptic Fill/Finish CMO Breakdown Data by Type (2015-2026)

  • 4.1 Global Pharmaceutical Aseptic Fill/Finish CMO Historic Market Size by Type (2015-2020)
  • 4.2 Global Pharmaceutical Aseptic Fill/Finish CMO Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical Aseptic Fill/Finish CMO Breakdown Data by Application (2015-2026)

  • 5.1 Global Pharmaceutical Aseptic Fill/Finish CMO Historic Market Size by Application (2015-2020)
  • 5.2 Global Pharmaceutical Aseptic Fill/Finish CMO Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Pharmaceutical Aseptic Fill/Finish CMO Market Size (2015-2026)
  • 6.2 North America Pharmaceutical Aseptic Fill/Finish CMO Market Size by Type (2015-2020)
  • 6.3 North America Pharmaceutical Aseptic Fill/Finish CMO Market Size by Application (2015-2020)
  • 6.4 North America Pharmaceutical Aseptic Fill/Finish CMO Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Pharmaceutical Aseptic Fill/Finish CMO Market Size (2015-2026)
  • 7.2 Europe Pharmaceutical Aseptic Fill/Finish CMO Market Size by Type (2015-2020)
  • 7.3 Europe Pharmaceutical Aseptic Fill/Finish CMO Market Size by Application (2015-2020)
  • 7.4 Europe Pharmaceutical Aseptic Fill/Finish CMO Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Pharmaceutical Aseptic Fill/Finish CMO Market Size (2015-2026)
  • 8.2 China Pharmaceutical Aseptic Fill/Finish CMO Market Size by Type (2015-2020)
  • 8.3 China Pharmaceutical Aseptic Fill/Finish CMO Market Size by Application (2015-2020)
  • 8.4 China Pharmaceutical Aseptic Fill/Finish CMO Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Pharmaceutical Aseptic Fill/Finish CMO Market Size (2015-2026)
  • 9.2 Japan Pharmaceutical Aseptic Fill/Finish CMO Market Size by Type (2015-2020)
  • 9.3 Japan Pharmaceutical Aseptic Fill/Finish CMO Market Size by Application (2015-2020)
  • 9.4 Japan Pharmaceutical Aseptic Fill/Finish CMO Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Pharmaceutical Aseptic Fill/Finish CMO Market Size (2015-2026)
  • 10.2 Southeast Asia Pharmaceutical Aseptic Fill/Finish CMO Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Pharmaceutical Aseptic Fill/Finish CMO Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Pharmaceutical Aseptic Fill/Finish CMO Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Boehringer Ingelheim
    • 11.1.1 Boehringer Ingelheim Company Details
    • 11.1.2 Boehringer Ingelheim Business Overview
    • 11.1.3 Boehringer Ingelheim Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.1.4 Boehringer Ingelheim Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020))
    • 11.1.5 Boehringer Ingelheim Recent Development
  • 11.2 Ajinomoto Bio-Pharma Services
    • 11.2.1 Ajinomoto Bio-Pharma Services Company Details
    • 11.2.2 Ajinomoto Bio-Pharma Services Business Overview
    • 11.2.3 Ajinomoto Bio-Pharma Services Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.2.4 Ajinomoto Bio-Pharma Services Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.2.5 Ajinomoto Bio-Pharma Services Recent Development
  • 11.3 Dalton
    • 11.3.1 Dalton Company Details
    • 11.3.2 Dalton Business Overview
    • 11.3.3 Dalton Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.3.4 Dalton Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.3.5 Dalton Recent Development
  • 11.4 Symbiosis Pharmaceutical Services
    • 11.4.1 Symbiosis Pharmaceutical Services Company Details
    • 11.4.2 Symbiosis Pharmaceutical Services Business Overview
    • 11.4.3 Symbiosis Pharmaceutical Services Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.4.4 Symbiosis Pharmaceutical Services Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.4.5 Symbiosis Pharmaceutical Services Recent Development
  • 11.5 Catalent Pharma Solutions
    • 11.5.1 Catalent Pharma Solutions Company Details
    • 11.5.2 Catalent Pharma Solutions Business Overview
    • 11.5.3 Catalent Pharma Solutions Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.5.4 Catalent Pharma Solutions Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.5.5 Catalent Pharma Solutions Recent Development
  • 11.6 Vetter Pharma
    • 11.6.1 Vetter Pharma Company Details
    • 11.6.2 Vetter Pharma Business Overview
    • 11.6.3 Vetter Pharma Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.6.4 Vetter Pharma Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.6.5 Vetter Pharma Recent Development
  • 11.7 Afton Scientific
    • 11.7.1 Afton Scientific Company Details
    • 11.7.2 Afton Scientific Business Overview
    • 11.7.3 Afton Scientific Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.7.4 Afton Scientific Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.7.5 Afton Scientific Recent Development
  • 11.8 HALIX
    • 11.8.1 HALIX Company Details
    • 11.8.2 HALIX Business Overview
    • 11.8.3 HALIX Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.8.4 HALIX Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.8.5 HALIX Recent Development
  • 11.9 NNE (Novo Nordisk Engineering A/S)
    • 11.9.1 NNE (Novo Nordisk Engineering A/S) Company Details
    • 11.9.2 NNE (Novo Nordisk Engineering A/S) Business Overview
    • 11.9.3 NNE (Novo Nordisk Engineering A/S) Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.9.4 NNE (Novo Nordisk Engineering A/S) Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.9.5 NNE (Novo Nordisk Engineering A/S) Recent Development
  • 11.10 LSNE Contract Manufacturing
    • 11.10.1 LSNE Contract Manufacturing Company Details
    • 11.10.2 LSNE Contract Manufacturing Business Overview
    • 11.10.3 LSNE Contract Manufacturing Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 11.10.4 LSNE Contract Manufacturing Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 11.10.5 LSNE Contract Manufacturing Recent Development
  • 11.11 GSK
    • 10.11.1 GSK Company Details
    • 10.11.2 GSK Business Overview
    • 10.11.3 GSK Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.11.4 GSK Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.11.5 GSK Recent Development
  • 11.12 Baxter BioPharma Solutions
    • 10.12.1 Baxter BioPharma Solutions Company Details
    • 10.12.2 Baxter BioPharma Solutions Business Overview
    • 10.12.3 Baxter BioPharma Solutions Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.12.4 Baxter BioPharma Solutions Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.12.5 Baxter BioPharma Solutions Recent Development
  • 11.13 Jubilant HollisterStier
    • 10.13.1 Jubilant HollisterStier Company Details
    • 10.13.2 Jubilant HollisterStier Business Overview
    • 10.13.3 Jubilant HollisterStier Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.13.4 Jubilant HollisterStier Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.13.5 Jubilant HollisterStier Recent Development
  • 11.14 GRAM (Grand River Aseptic Manufacturing)
    • 10.14.1 GRAM (Grand River Aseptic Manufacturing) Company Details
    • 10.14.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
    • 10.14.3 GRAM (Grand River Aseptic Manufacturing) Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.14.4 GRAM (Grand River Aseptic Manufacturing) Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.14.5 GRAM (Grand River Aseptic Manufacturing) Recent Development
  • 11.15 Fresenius Kabi
    • 10.15.1 Fresenius Kabi Company Details
    • 10.15.2 Fresenius Kabi Business Overview
    • 10.15.3 Fresenius Kabi Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.15.4 Fresenius Kabi Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.15.5 Fresenius Kabi Recent Development
  • 11.16 Emergent BioSolutions
    • 10.16.1 Emergent BioSolutions Company Details
    • 10.16.2 Emergent BioSolutions Business Overview
    • 10.16.3 Emergent BioSolutions Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.16.4 Emergent BioSolutions Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.16.5 Emergent BioSolutions Recent Development
  • 11.17 Vigene Biosciences
    • 10.17.1 Vigene Biosciences Company Details
    • 10.17.2 Vigene Biosciences Business Overview
    • 10.17.3 Vigene Biosciences Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.17.4 Vigene Biosciences Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.17.5 Vigene Biosciences Recent Development
  • 11.18 Akron
    • 10.18.1 Akron Company Details
    • 10.18.2 Akron Business Overview
    • 10.18.3 Akron Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.18.4 Akron Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.18.5 Akron Recent Development
  • 11.19 Cobra Biologics
    • 10.19.1 Cobra Biologics Company Details
    • 10.19.2 Cobra Biologics Business Overview
    • 10.19.3 Cobra Biologics Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.19.4 Cobra Biologics Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.19.5 Cobra Biologics Recent Development
  • 11.20 WuXi Biologics
    • 10.20.1 WuXi Biologics Company Details
    • 10.20.2 WuXi Biologics Business Overview
    • 10.20.3 WuXi Biologics Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.20.4 WuXi Biologics Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.20.5 WuXi Biologics Recent Development
  • 11.21 Jiangshu YAOHAI Bio-pharmaceutical
    • 10.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Details
    • 10.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
    • 10.21.3 Jiangshu YAOHAI Bio-pharmaceutical Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.21.4 Jiangshu YAOHAI Bio-pharmaceutical Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Development
  • 11.22 Techdow
    • 10.22.1 Techdow Company Details
    • 10.22.2 Techdow Business Overview
    • 10.22.3 Techdow Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.22.4 Techdow Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.22.5 Techdow Recent Development
  • 11.23 Cozzoli
    • 10.23.1 Cozzoli Company Details
    • 10.23.2 Cozzoli Business Overview
    • 10.23.3 Cozzoli Pharmaceutical Aseptic Fill/Finish CMO Introduction
    • 10.23.4 Cozzoli Revenue in Pharmaceutical Aseptic Fill/Finish CMO Business (2015-2020)
    • 10.23.5 Cozzoli Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Pharmaceutical Aseptic Fill/Finish CMO market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Aseptic Fill/Finish CMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Ampoule Filling Services
    Vial Filling Services
    Aseptic Prefilled Syringes/Sterile Syringe Filling Services
    Others

    Market segment by Application, split into
    Vaccines
    Commercial Drug products
    Clinical Drug products
    Antibiotics
    Diagnostics and Reagents
    Others

    Based on regional and country-level analysis, the Pharmaceutical Aseptic Fill/Finish CMO market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutical Aseptic Fill/Finish CMO market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Boehringer Ingelheim
    Ajinomoto Bio-Pharma Services
    Dalton
    Symbiosis Pharmaceutical Services
    Catalent Pharma Solutions
    Vetter Pharma
    Afton Scientific
    HALIX
    NNE (Novo Nordisk Engineering A/S)
    LSNE Contract Manufacturing
    GSK
    Baxter BioPharma Solutions
    Jubilant HollisterStier
    GRAM (Grand River Aseptic Manufacturing)
    Fresenius Kabi
    Emergent BioSolutions
    Vigene Biosciences
    Akron
    Cobra Biologics
    WuXi Biologics
    Jiangshu YAOHAI Bio-pharmaceutical
    Techdow


    Summary:
    Get latest Market Research Reports on Pharmaceutical Aseptic Fill/Finish CMO. Industry analysis & Market Report on Pharmaceutical Aseptic Fill/Finish CMO is a syndicated market report, published as Global Pharmaceutical Aseptic Fill/Finish CMO Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Pharmaceutical Aseptic Fill/Finish CMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,966.68
    4,450.02
    5,933.37
    3,289.23
    4,933.85
    6,578.47
    411,648.90
    617,473.35
    823,297.80
    292,278.87
    438,418.30
    584,557.74
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report